J&J Gets Pa.'s Off-Label Risperdal Suit Tossed
A state court judge on Monday threw out the commonwealth of Pennsylvania's suit alleging that Johnson & Johnson unit Janssen Pharmaceutica Inc. had improperly marketed the antipsychotic drug Risperdal, and an...To view the full article, register now.
Already a subscriber? Click here to view full article